Because lower serum levels of irisin were found in patients with osteopenia/osteoporosis than in healthy controls, the authors assessed the existence of a correlation between this reduction and cellular senescence by studying the expression of the senescence marker p21 in both bone and muscle. The gene discussed is FNDC5; the disease is osteoporosis.